Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Melanoma: HELP
Ester Simeone
Based on 37 articles published since 2009
(Why 37 articles?)
||||
Expertise Level
The expertise of Ester Simeone ranks in the
  • Top 0.13%
  • ... of 106,334 published authors worldwide on Melanoma
  • ... from 2009 through 2019
  • ... based on contributions to 37 articles on the topic.
Graphical view (beta)
Get your prestigious
Expert badge
similar to this:
 
Aliases Simeone, Ester   ·   Simeone, E
Work Locations
Details
Most likely:    Istituto Nazionale Tumori IRCCS Fondazione Pascale      
2019
  • Unit of Tumor Epigenetics, IRCCS Ospedale Policlinico San Martino, Largo Rosanna Benzi, 10, 16132, Genoa, Italy. · Unit of Clinical Epidemiology, IRCCS Ospedale Policlinico San Martino, Genoa, Italy. · Unit of Tumor Epigenetics, IRCCS Ospedale Policlinico San Martino, Largo Rosanna Benzi, 10, 16132, Genoa, Italy. · Department of Internal Medicine, University of Genoa, Genoa, Italy. · Department of Health Sciences, University of Genoa, Genoa, Italy. · Department of Medical Oncology, IRCCS Ospedale Policlinico San Martino, Genoa, Italy. · Oncology of Melanoma Unit, European Institute of Oncology, Milan, Italy. · iTeos Therapeutics, Gosselies, Belgium. · Department of Medical Oncology and Molecular Genetics Laboratory, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy. · Istituto Dermopatico dell'Immacolata IDI-IRCCS, Rome, Italy. · Sapienza University of Rome, Rome, Italy. · Department of Medical Sciences, Dermatologic Clinic, University of Turin, Turin, Italy. · Department of Medical Sciences, Section of Surgical Pathology, University of Turin, Turin, Italy. · Melanoma, Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione'G. Pascale', Naples, Italy. · Pubmed 30311027
2018
  • Department of Medical Oncology, Ospedale Policlinico San Martino, Genova, Italy. · Unit of Clinical Epidemiology, Ospedale Policlinico San Martino, Genova, Italy. · Unit of Tumor Epigenetics, Ospedale Policlinico San Martino, Genova, Italy. · Unit of Tumor Epigenetics, Ospedale Policlinico San Martino, Genova, Italy; Department of Health Sciences, University of Genova, Italy. · Oncology of Melanoma Unit, European Institute of Oncology, Milan, Italy. · Melanoma, Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione G. Pascale, Naples, Italy. · Istituto Dermopatico dell'Immacolata IDI-IRCCS, Rome, Italy. · Istituto Dermopatico dell'Immacolata IDI-IRCCS, Rome, Italy; Medical Oncology, Sant'Andrea Hospital, Sapienza University of Rome, Rome, Italy. · Department of Medical Oncology and Molecular Genetics Laboratory, IRCCS Istituto Tumori Giovanni Paolo II, Bari, Italy. · Unit of Medical Oncology, Department of Oncology and Hematology, Papa Giovanni XXIII Hospital, Bergamo, Italy. · Dermatologic Clinic, Department of Medical Sciences, University of Turin, Turin, Italy. · Section of Surgical Pathology, Department of Medical Sciences, University of Turin, Turin, Italy. · Immunotherapy and Cell Therapy, IRCCS-IRST, Meldola, Italy. · Endocrinology Unit, Department of Internal Medicine (DiMI), University of Genova, Italy. · Unit of Tumor Epigenetics, Ospedale Policlinico San Martino, Genova, Italy. Electronic address: · Pubmed 29743138
2017
  • Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Pubmed 28537004
  • Melanoma, Cancer Immunotherapy and Innovative Therapies Unit, Istituto Nazionale Tumori di Napoli Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Melanoma, Cancer Immunotherapy and Innovative Therapies Unit, Istituto Nazionale Tumori di Napoli Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Pubmed 28058658
  • Department of Molecular Medicine and Medical Biotechnologies, Federico II University, Via Pansini, 5, 80131, Naples, Italy. · Melanoma Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · CEINGE Biotecnologie Avanzate, Naples, Italy. · Melanoma Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Department of Molecular Medicine and Medical Biotechnologies, Federico II University, Via Pansini, 5, 80131, Naples, Italy. · Pubmed 28434031
2016
  • Istituto Nazionale Tumori Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Istituto Nazionale Tumori Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Pubmed 27604993
  • Department of Dermatology, University Medical Center Tübingen, Tübingen, Germany. · Department of Immunology, University of Tübingen, Tübingen, Germany. · Department of Dermatology, University Medical Center Tübingen, Tübingen, Germany. · Department of Dermatology and National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany. · German Cancer Consortium (DKTK), Heidelberg, Germany. · Department of Dermatology, University Hospital of Munich, Munich, Germany. · Memorial Sloan Kettering Cancer Center, New York, New York. · Weill Cornell Medical College, New York, New York. · Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. · Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. · Department of Dermatology, University of Zürich, Zürich, Switzerland. · Department of Dermatology, University Hospital, West German Cancer Center, University Duisburg-Essen, Essen, Germany. · Division of Medical Oncology and Immunotherapy, University Hospital of Siena, Siena, Italy. · Department of Dermatology and Venereology, University Hospital of Cologne, Cologne, Germany. · Department of Dermatology, University Hospital Schleswig-Holstein, Kiel, Germany. · Department of Dermatology, University Hospital Erlangen, Erlangen, Germany. · Skin Cancer Center, Department of Dermatology, Hannover Medical School, Hannover, Germany. · Department of Dermatology and Allergology, University Hospital of Marburg, Marburg, Germany. · Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Department of Dermatology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, Germany. · Department of Oncology, Service of Medical Oncology, Institut Curie, Paris, France. · Department of Dermatology, University Medical Center Dresden, Dresden, Germany. · Departments of Clinical Epidemiology and Applied Biostatistics, University of Tübingen, Tübingen, Germany. · Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Pubmed 27185375
  • Oncology of Melanoma Unit, European Institute of Oncology, Milan. · Medical Oncology and Immunotherapy, Istituto Nazionale Tumori Fondazione 'G. Pascale', Naples. · Melanoma Oncology Unit, Veneto Region Oncology Research Institute, Padua. · Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milan. · Istituto Toscano Tumori, University Hospital of Siena, Siena. · IV Oncology Division, Istituto Dermopatico dell'Immacolata IRCCS, Rome. · Immunotherapy and Somatic Cell Therapy Unit, Scientific Institute of Romagna, Meldola. · Department of Medical Oncology, National Institute for Cancer Research, IRCCS San Martino, Genoa. · Dermatologic Clinic, Department of Medical Sciences, University of Turin, Turin. · Unit of Medical Oncology, Department of Oncology and Hematology, Papa Giovanni XXIII Hospital, Bergamo. · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan. · Statistical Unit, Regina Elena National Cancer Institute, Rome, Italy. · Oncology of Melanoma Unit, European Institute of Oncology, Milan · Pubmed 26802161
2015
  • Unit of Melanoma, Cancer Immunotherapy and Innovative Therapies, Istituto Nazionale Tumori Fondazione G. Pascale, Napoli, Italy. Electronic address: · Unit of Melanoma, Cancer Immunotherapy and Innovative Therapies, Istituto Nazionale Tumori Fondazione G. Pascale, Napoli, Italy. Electronic address: · Oncology Division, Department of Clinical Medicine, University "Federico II" of Naples, Italy. Electronic address: · Oncology Division, Department of Clinical Medicine, University "Federico II" of Naples, Italy. Electronic address: · Unit of Melanoma, Cancer Immunotherapy and Innovative Therapies, Istituto Nazionale Tumori Fondazione G. Pascale, Napoli, Italy. Electronic address: · Pubmed 25511547
  • Medical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, Siena. · Medical Oncology and Innovative Therapies, Fondazione 'G. Pascale', National Cancer Institute, Naples. · Medical Oncology 2, IRCCS, AOU San Martino, Genoa. · Melanoma Unit, San Raffaele Scientific Institute, Milan. · Immunotherapy and Somatic Cell Therapy Unit, Scientific Institute of Romagna, Meldola. · Melanoma and Sarcoma Unit, National Institute for Cancer Research, Milan. · Dermatoncological Division, Istituto Europeo di Oncologia, Milan. · Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milan. · Statistical Unit, Regina Elena National Cancer Institute, Rome. · Medical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, Siena Italian Network for Tumor Biotherapy (NIBIT), Siena, Italy. · Medical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, Siena · Pubmed 25538176
  • Department of Molecular Medicine and Medical Biotechnologies, Federico II University, Naples, Italy. · Department of Advanced Biomedical Sciences, Federico II University, Naples, Italy. · Melanoma Unit, National Cancer Institute 'G. Pascale Foundation', Naples, Italy. · Dermatology Section, Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy. · Department of Biological Science, University of Portsmouth, Portsmouth, UK. · Pubmed 25895097
  • Department of Surgery "Melanoma, Soft Tissues, Head and Neck, Skin Cancers", National Cancer Institute "G. Pascale", Via M. Semmola, 80131, Naples, Italy. · Department of Surgery "Melanoma, Soft Tissues, Head and Neck, Skin Cancers", National Cancer Institute "G. Pascale", Via M. Semmola, 80131, Naples, Italy. · Department of Surgery "Melanoma, Soft Tissues, Head and Neck, Skin Cancers", National Cancer Institute "G. Pascale", Via M. Semmola, 80131, Naples, Italy. · Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, National Cancer Institute "G. Pascale", 80131, Naples, Italy. · Department of Pathology, National Cancer Institute "G. Pascale", 80131, Naples, Italy. · Department of Surgery "Melanoma, Soft Tissues, Head and Neck, Skin Cancers", National Cancer Institute "G. Pascale", Via M. Semmola, 80131, Naples, Italy. · Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, National Cancer Institute "G. Pascale", 80131, Naples, Italy. · Department of Surgery "Melanoma, Soft Tissues, Head and Neck, Skin Cancers", National Cancer Institute "G. Pascale", Via M. Semmola, 80131, Naples, Italy. · Pubmed 25890364
2014
  • Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori Fondazione "G. Pascale", Naples, Italy. · Pubmed 24258976
  • Melanoma Cancer Unit, Veneto Institute of Oncology IOV-IRCCS, Via Gattamelata, 64, 35128 Padua, Italy. · Melanoma, Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione 'G Pascale', Via Cappella dei Cangiani, 1, 80131 Naples, Italy. · Medical Oncology and Immunotherapy Unit, University Hospital of Siena, Istituto Toscano Tumori, Strada delle Scotte, 14, 53100 Siena, Italy. · 1] Medical Oncology, Dermopathic Institute of the Immaculate IDI-IRCCS, Via dei Monti di Creta, 104, 00167 Rome, Italy [2] Medical Oncology, Sant'Andrea Hospital, Sapienza University of Rome, Via di Grottarossa, 1035-39, 00189 Rome, Italy. · Medical Oncology, Dermopathic Institute of the Immaculate IDI-IRCCS, Via dei Monti di Creta, 104, 00167 Rome, Italy. · Divisione Melanoma, Istituto Europeo di Oncologia, Via Ripamonti, 435, 20141 Milan, Italy. · Oncology of Melanoma Unit, Istituto Europeo di Oncologia, Via Ripamonti, 435, 20141 Milan, Italy. · Department of Medical Oncology A, San Martino Hospital, National Institute for Cancer Research, L.go R. Benzi, 10, 16132 Genoa, Italy. · Dermatologic Clinic, Department of Medical Sciences, University of Torino, San Giovanni Battista di Torino, Via Cherasco, 23, 10126 Turin, Italy. · Division of Medical Oncology, Institute for Cancer Research and Treatment, IRCC, Piedmont Oncology Foundation, Strada Provinciale, 142, 10060 Candiolo, Italy. · Unit of Medical Oncology, Papa Giovanni XXIII Hospital, Piazza OMS-Organizzazione Mondiale della Sanità, 1, 24127 Bergamo, Italy. · Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian, 1, 20133 Milan, Italy. · Pubmed 24619072
  • Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, IRCCS, Istituto Nazionale Tumori Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Pubmed 24695951
2013
  • Paolo A. Ascierto, Ester Simeone, Instituto Nazionale Tumori Fondazione "G. Pascale," Napoli, Italy · David Minor, California Pacific Center for Melanoma Research and Treatment, San Francisco · Antoni Ribas, Jonsson Comprehensive Cancer Center, University of California, Los Angeles · Omid Hamid, Experimental Therapeutics/Immunotherapy, The Angeles Clinic and Research Institute, Los Angeles, CA · Anne O'Hagan, Niki Arya, Mary Guckert, Anne-Marie Martin, Jolly Mazumdar, Vicki L. Goodman, GlaxoSmithKline Oncology, Collegeville · Ravi Amaravadi, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA · Kevin B. Kim, The University of Texas MD Anderson Cancer Center, Houston, TX · Celeste Lebbe, Assistance Publique-Hôpitaux de Paris, Hôpital Saint Louis, Paris, Université Paris Diderot, Paris · Jean-Jacques Grob, Aix-Marseille University, Assistance Publique-Hôpitaux de Marseille, Hôpital Timone, Marseille, France · Dirk Schadendorf, University Hospital Essen, Essen · Tabea Wilhelm, Uwe Trefzer, Charité-Universitätsmedizin, Berlin, Germany · Richard F. Kefford, Georgina V. Long, Westmead Hospital and Melanoma Institute Australia, University of Sydney, Sydney, Australia. · Pubmed 23918947
2012
  • Unit of Medical Oncology and Innovative Therapy, Istituto Nazionale Tumori Fondazione G. Pascale, Naples, Italy. · Pubmed 22524673
2015
  • O.U. Melanoma, Cancer Immunotherapy and Innovative Therapies, National Cancer Institute of Naples "G. Pascale" Foundation, Naples, Italy. · Pubmed 26175403
  • aDivision of Melanoma, Cancer Immunotherapy and Innovative Therapies bDivision of Melanoma and Skin Cancer cDepartment of Diagnostic Imaging, Radiant and Metabolic Therapy, Division of Radiology dDivision of Radiotherapy, Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. · Pubmed 25622086
2014
  • Istituto Nazionale Tunori Fondazione 'G. Pascale', Naples, Italy. · Pubmed 24419498
  • Istituto Nazionale Tumori Fondazione 'G, Pascale', Napoli, Italy. · Pubmed 24885479
  • Melanoma, Cancer Immunotherapy, and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione "G. Pascale", Naples, Italy,1. · Pubmed 24484235
2013
  • Department of Melanoma, Istituto Nazionale Tumori Fondazione Pascale, Via Mariano Semmola, 80131, Naples, Italy. · Pubmed 23402397
  • Unit of Surgery "Melanoma - Soft Tissues - Head & Neck - Skin Cancers", Istituto Nazionale per lo Studio e la cura dei tumori "Fondazione G,Pascale" IRCCS, Naples, Italy. · Pubmed 24289268
  • Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Department of Melanoma, Istituto Nazionale Tumori Fondazione G. Pascale, Naples, Italy. · Pubmed 23497384
2012
  • Department of Melanoma, Istituto Nazionale Tumori Fondazione G, Pascale, Naples, Italy. · Pubmed 22554099
  • Unit of Medical Oncology and Innovative Therapy, G Pascale Institute of National Tumor Foundation, Naples, Italy. · Pubmed 22993335
  • Melanoma, Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione G, Pascale, Naples, Italy. · Pubmed 22640478
2010
  • Unit of Medical Oncology and Innovative Therapy and Melanoma Cooperative Group, National Tumor Institute, Naples, Italy. · Pubmed 20712892
  • National Cancer Institute, Naples, Italy. · Pubmed 20707921
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 37 total) written by Ester Simeone about Melanoma:

  • Soluble CTLA-4 as a favorable predictive biomarker in metastatic melanoma patients treated with ipilimumab: an Italian melanoma intergroup study. 2019
  • CTLA-4 gene variant -1661A>G may predict the onset of endocrine adverse events in metastatic melanoma patients treated with ipilimumab. 2018
  • MEK Inhibitors in the Treatment of Metastatic Melanoma and Solid Tumors. 2017
  • Combination Treatment of Patients with BRAF-Mutant Melanoma: A New Standard of Care. 2017
  • FKBP51s signature in peripheral blood mononuclear cells of melanoma patients as a possible predictive factor for immunotherapy. 2017
  • Complete response to nivolumab monotherapy in a treatment-naive, BRAF wild-type patient with advanced mucosal melanoma and elevated lactate dehydrogenase: a case report from a phase III trial. 2016
  • Baseline Biomarkers for Outcome of Melanoma Patients Treated with Pembrolizumab. 2016
  • Antitumor Activity of BRAF Inhibitor and IFNα Combination in BRAF-Mutant Melanoma. 2016
  • Baseline neutrophils and derived neutrophil-to-lymphocyte ratio: prognostic relevance in metastatic melanoma patients receiving ipilimumab. 2016
  • Novel mechanisms and therapeutic approaches in melanoma: targeting the MAPK pathway. 2015
Show List of Full Article Records
Google Searches

Learn more about Ester Simeone using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Istituto Nazionale Tumori IRCCS Fondazione Pascale
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Istituto Nazionale Tumori IRCCS Fondazione Pascale
2019
  • Unit of Tumor Epigenetics, IRCCS Ospedale Policlinico San Martino, Largo Rosanna Benzi, 10, 16132, Genoa, Italy. · Unit of Clinical Epidemiology, IRCCS Ospedale Policlinico San Martino, Genoa, Italy. · Unit of Tumor Epigenetics, IRCCS Ospedale Policlinico San Martino, Largo Rosanna Benzi, 10, 16132, Genoa, Italy. · Department of Internal Medicine, University of Genoa, Genoa, Italy. · Department of Health Sciences, University of Genoa, Genoa, Italy. · Department of Medical Oncology, IRCCS Ospedale Policlinico San Martino, Genoa, Italy. · Oncology of Melanoma Unit, European Institute of Oncology, Milan, Italy. · iTeos Therapeutics, Gosselies, Belgium. · Department of Medical Oncology and Molecular Genetics Laboratory, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy. · Istituto Dermopatico dell'Immacolata IDI-IRCCS, Rome, Italy. · Sapienza University of Rome, Rome, Italy. · Department of Medical Sciences, Dermatologic Clinic, University of Turin, Turin, Italy. · Department of Medical Sciences, Section of Surgical Pathology, University of Turin, Turin, Italy. · Melanoma, Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione'G. Pascale', Naples, Italy. · Pubmed 30311027
2018
  • Department of Medical Oncology, Ospedale Policlinico San Martino, Genova, Italy. · Unit of Clinical Epidemiology, Ospedale Policlinico San Martino, Genova, Italy. · Unit of Tumor Epigenetics, Ospedale Policlinico San Martino, Genova, Italy. · Unit of Tumor Epigenetics, Ospedale Policlinico San Martino, Genova, Italy; Department of Health Sciences, University of Genova, Italy. · Oncology of Melanoma Unit, European Institute of Oncology, Milan, Italy. · Melanoma, Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione G. Pascale, Naples, Italy. · Istituto Dermopatico dell'Immacolata IDI-IRCCS, Rome, Italy. · Istituto Dermopatico dell'Immacolata IDI-IRCCS, Rome, Italy; Medical Oncology, Sant'Andrea Hospital, Sapienza University of Rome, Rome, Italy. · Department of Medical Oncology and Molecular Genetics Laboratory, IRCCS Istituto Tumori Giovanni Paolo II, Bari, Italy. · Unit of Medical Oncology, Department of Oncology and Hematology, Papa Giovanni XXIII Hospital, Bergamo, Italy. · Dermatologic Clinic, Department of Medical Sciences, University of Turin, Turin, Italy. · Section of Surgical Pathology, Department of Medical Sciences, University of Turin, Turin, Italy. · Immunotherapy and Cell Therapy, IRCCS-IRST, Meldola, Italy. · Endocrinology Unit, Department of Internal Medicine (DiMI), University of Genova, Italy. · Unit of Tumor Epigenetics, Ospedale Policlinico San Martino, Genova, Italy. Electronic address: · Pubmed 29743138
2017
  • Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Pubmed 28537004
  • Melanoma, Cancer Immunotherapy and Innovative Therapies Unit, Istituto Nazionale Tumori di Napoli Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Melanoma, Cancer Immunotherapy and Innovative Therapies Unit, Istituto Nazionale Tumori di Napoli Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Pubmed 28058658
  • Department of Molecular Medicine and Medical Biotechnologies, Federico II University, Via Pansini, 5, 80131, Naples, Italy. · Melanoma Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · CEINGE Biotecnologie Avanzate, Naples, Italy. · Melanoma Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Department of Molecular Medicine and Medical Biotechnologies, Federico II University, Via Pansini, 5, 80131, Naples, Italy. · Pubmed 28434031
2016
  • Istituto Nazionale Tumori Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Istituto Nazionale Tumori Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Pubmed 27604993
  • Department of Dermatology, University Medical Center Tübingen, Tübingen, Germany. · Department of Immunology, University of Tübingen, Tübingen, Germany. · Department of Dermatology, University Medical Center Tübingen, Tübingen, Germany. · Department of Dermatology and National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany. · German Cancer Consortium (DKTK), Heidelberg, Germany. · Department of Dermatology, University Hospital of Munich, Munich, Germany. · Memorial Sloan Kettering Cancer Center, New York, New York. · Weill Cornell Medical College, New York, New York. · Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. · Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. · Department of Dermatology, University of Zürich, Zürich, Switzerland. · Department of Dermatology, University Hospital, West German Cancer Center, University Duisburg-Essen, Essen, Germany. · Division of Medical Oncology and Immunotherapy, University Hospital of Siena, Siena, Italy. · Department of Dermatology and Venereology, University Hospital of Cologne, Cologne, Germany. · Department of Dermatology, University Hospital Schleswig-Holstein, Kiel, Germany. · Department of Dermatology, University Hospital Erlangen, Erlangen, Germany. · Skin Cancer Center, Department of Dermatology, Hannover Medical School, Hannover, Germany. · Department of Dermatology and Allergology, University Hospital of Marburg, Marburg, Germany. · Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Department of Dermatology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, Germany. · Department of Oncology, Service of Medical Oncology, Institut Curie, Paris, France. · Department of Dermatology, University Medical Center Dresden, Dresden, Germany. · Departments of Clinical Epidemiology and Applied Biostatistics, University of Tübingen, Tübingen, Germany. · Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Pubmed 27185375
  • Oncology of Melanoma Unit, European Institute of Oncology, Milan. · Medical Oncology and Immunotherapy, Istituto Nazionale Tumori Fondazione 'G. Pascale', Naples. · Melanoma Oncology Unit, Veneto Region Oncology Research Institute, Padua. · Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milan. · Istituto Toscano Tumori, University Hospital of Siena, Siena. · IV Oncology Division, Istituto Dermopatico dell'Immacolata IRCCS, Rome. · Immunotherapy and Somatic Cell Therapy Unit, Scientific Institute of Romagna, Meldola. · Department of Medical Oncology, National Institute for Cancer Research, IRCCS San Martino, Genoa. · Dermatologic Clinic, Department of Medical Sciences, University of Turin, Turin. · Unit of Medical Oncology, Department of Oncology and Hematology, Papa Giovanni XXIII Hospital, Bergamo. · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan. · Statistical Unit, Regina Elena National Cancer Institute, Rome, Italy. · Oncology of Melanoma Unit, European Institute of Oncology, Milan · Pubmed 26802161
2015
  • Unit of Melanoma, Cancer Immunotherapy and Innovative Therapies, Istituto Nazionale Tumori Fondazione G. Pascale, Napoli, Italy. Electronic address: · Unit of Melanoma, Cancer Immunotherapy and Innovative Therapies, Istituto Nazionale Tumori Fondazione G. Pascale, Napoli, Italy. Electronic address: · Oncology Division, Department of Clinical Medicine, University "Federico II" of Naples, Italy. Electronic address: · Oncology Division, Department of Clinical Medicine, University "Federico II" of Naples, Italy. Electronic address: · Unit of Melanoma, Cancer Immunotherapy and Innovative Therapies, Istituto Nazionale Tumori Fondazione G. Pascale, Napoli, Italy. Electronic address: · Pubmed 25511547
  • Medical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, Siena. · Medical Oncology and Innovative Therapies, Fondazione 'G. Pascale', National Cancer Institute, Naples. · Medical Oncology 2, IRCCS, AOU San Martino, Genoa. · Melanoma Unit, San Raffaele Scientific Institute, Milan. · Immunotherapy and Somatic Cell Therapy Unit, Scientific Institute of Romagna, Meldola. · Melanoma and Sarcoma Unit, National Institute for Cancer Research, Milan. · Dermatoncological Division, Istituto Europeo di Oncologia, Milan. · Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milan. · Statistical Unit, Regina Elena National Cancer Institute, Rome. · Medical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, Siena Italian Network for Tumor Biotherapy (NIBIT), Siena, Italy. · Medical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, Siena · Pubmed 25538176
  • Department of Molecular Medicine and Medical Biotechnologies, Federico II University, Naples, Italy. · Department of Advanced Biomedical Sciences, Federico II University, Naples, Italy. · Melanoma Unit, National Cancer Institute 'G. Pascale Foundation', Naples, Italy. · Dermatology Section, Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy. · Department of Biological Science, University of Portsmouth, Portsmouth, UK. · Pubmed 25895097
  • Department of Surgery "Melanoma, Soft Tissues, Head and Neck, Skin Cancers", National Cancer Institute "G. Pascale", Via M. Semmola, 80131, Naples, Italy. · Department of Surgery "Melanoma, Soft Tissues, Head and Neck, Skin Cancers", National Cancer Institute "G. Pascale", Via M. Semmola, 80131, Naples, Italy. · Department of Surgery "Melanoma, Soft Tissues, Head and Neck, Skin Cancers", National Cancer Institute "G. Pascale", Via M. Semmola, 80131, Naples, Italy. · Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, National Cancer Institute "G. Pascale", 80131, Naples, Italy. · Department of Pathology, National Cancer Institute "G. Pascale", 80131, Naples, Italy. · Department of Surgery "Melanoma, Soft Tissues, Head and Neck, Skin Cancers", National Cancer Institute "G. Pascale", Via M. Semmola, 80131, Naples, Italy. · Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, National Cancer Institute "G. Pascale", 80131, Naples, Italy. · Department of Surgery "Melanoma, Soft Tissues, Head and Neck, Skin Cancers", National Cancer Institute "G. Pascale", Via M. Semmola, 80131, Naples, Italy. · Pubmed 25890364
2014
  • Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori Fondazione "G. Pascale", Naples, Italy. · Pubmed 24258976
  • Melanoma Cancer Unit, Veneto Institute of Oncology IOV-IRCCS, Via Gattamelata, 64, 35128 Padua, Italy. · Melanoma, Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione 'G Pascale', Via Cappella dei Cangiani, 1, 80131 Naples, Italy. · Medical Oncology and Immunotherapy Unit, University Hospital of Siena, Istituto Toscano Tumori, Strada delle Scotte, 14, 53100 Siena, Italy. · 1] Medical Oncology, Dermopathic Institute of the Immaculate IDI-IRCCS, Via dei Monti di Creta, 104, 00167 Rome, Italy [2] Medical Oncology, Sant'Andrea Hospital, Sapienza University of Rome, Via di Grottarossa, 1035-39, 00189 Rome, Italy. · Medical Oncology, Dermopathic Institute of the Immaculate IDI-IRCCS, Via dei Monti di Creta, 104, 00167 Rome, Italy. · Divisione Melanoma, Istituto Europeo di Oncologia, Via Ripamonti, 435, 20141 Milan, Italy. · Oncology of Melanoma Unit, Istituto Europeo di Oncologia, Via Ripamonti, 435, 20141 Milan, Italy. · Department of Medical Oncology A, San Martino Hospital, National Institute for Cancer Research, L.go R. Benzi, 10, 16132 Genoa, Italy. · Dermatologic Clinic, Department of Medical Sciences, University of Torino, San Giovanni Battista di Torino, Via Cherasco, 23, 10126 Turin, Italy. · Division of Medical Oncology, Institute for Cancer Research and Treatment, IRCC, Piedmont Oncology Foundation, Strada Provinciale, 142, 10060 Candiolo, Italy. · Unit of Medical Oncology, Papa Giovanni XXIII Hospital, Piazza OMS-Organizzazione Mondiale della Sanità, 1, 24127 Bergamo, Italy. · Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian, 1, 20133 Milan, Italy. · Pubmed 24619072
  • Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, IRCCS, Istituto Nazionale Tumori Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Pubmed 24695951
2013
  • Paolo A. Ascierto, Ester Simeone, Instituto Nazionale Tumori Fondazione "G. Pascale," Napoli, Italy · David Minor, California Pacific Center for Melanoma Research and Treatment, San Francisco · Antoni Ribas, Jonsson Comprehensive Cancer Center, University of California, Los Angeles · Omid Hamid, Experimental Therapeutics/Immunotherapy, The Angeles Clinic and Research Institute, Los Angeles, CA · Anne O'Hagan, Niki Arya, Mary Guckert, Anne-Marie Martin, Jolly Mazumdar, Vicki L. Goodman, GlaxoSmithKline Oncology, Collegeville · Ravi Amaravadi, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA · Kevin B. Kim, The University of Texas MD Anderson Cancer Center, Houston, TX · Celeste Lebbe, Assistance Publique-Hôpitaux de Paris, Hôpital Saint Louis, Paris, Université Paris Diderot, Paris · Jean-Jacques Grob, Aix-Marseille University, Assistance Publique-Hôpitaux de Marseille, Hôpital Timone, Marseille, France · Dirk Schadendorf, University Hospital Essen, Essen · Tabea Wilhelm, Uwe Trefzer, Charité-Universitätsmedizin, Berlin, Germany · Richard F. Kefford, Georgina V. Long, Westmead Hospital and Melanoma Institute Australia, University of Sydney, Sydney, Australia. · Pubmed 23918947
2012
  • Unit of Medical Oncology and Innovative Therapy, Istituto Nazionale Tumori Fondazione G. Pascale, Naples, Italy. · Pubmed 22524673
2015
  • O.U. Melanoma, Cancer Immunotherapy and Innovative Therapies, National Cancer Institute of Naples "G. Pascale" Foundation, Naples, Italy. · Pubmed 26175403
  • aDivision of Melanoma, Cancer Immunotherapy and Innovative Therapies bDivision of Melanoma and Skin Cancer cDepartment of Diagnostic Imaging, Radiant and Metabolic Therapy, Division of Radiology dDivision of Radiotherapy, Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. · Pubmed 25622086
2014
  • Istituto Nazionale Tunori Fondazione 'G. Pascale', Naples, Italy. · Pubmed 24419498
  • Istituto Nazionale Tumori Fondazione 'G, Pascale', Napoli, Italy. · Pubmed 24885479
  • Melanoma, Cancer Immunotherapy, and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione "G. Pascale", Naples, Italy,1. · Pubmed 24484235
2013
  • Department of Melanoma, Istituto Nazionale Tumori Fondazione Pascale, Via Mariano Semmola, 80131, Naples, Italy. · Pubmed 23402397
  • Unit of Surgery "Melanoma - Soft Tissues - Head & Neck - Skin Cancers", Istituto Nazionale per lo Studio e la cura dei tumori "Fondazione G,Pascale" IRCCS, Naples, Italy. · Pubmed 24289268
  • Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Department of Melanoma, Istituto Nazionale Tumori Fondazione G. Pascale, Naples, Italy. · Pubmed 23497384
2012
  • Department of Melanoma, Istituto Nazionale Tumori Fondazione G, Pascale, Naples, Italy. · Pubmed 22554099
  • Unit of Medical Oncology and Innovative Therapy, G Pascale Institute of National Tumor Foundation, Naples, Italy. · Pubmed 22993335
  • Melanoma, Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione G, Pascale, Naples, Italy. · Pubmed 22640478
2010
  • Unit of Medical Oncology and Innovative Therapy and Melanoma Cooperative Group, National Tumor Institute, Naples, Italy. · Pubmed 20712892
  • National Cancer Institute, Naples, Italy. · Pubmed 20707921
6 Other Locations Show
Yearly article counts 11347865020
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.